EUVIMEDEUVIMED entdecken
Open Access

Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNA

Nike K Simon, Stefanie Volz, Jussara Rios de Los Rios Reséndiz, Tatjana Wedig, Sophia H Montigel, Nathalie Schwarz, Karsten Richter, Dominic Helm, Michelle Neßling, Lin Zielske, Julia Berker, Sophia Russeck und 6 weitere

Extracellular Vesicles and Circulating Nucleic Acids · 09.10.2025 · 626-50

DOI: 10.20517/evcna.2025.44 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Extracellular Vesicles and Circulating Nucleic Acids, online erschienen am 09.10.2025. Verfasst von Nike K Simon und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg 69120, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Liquid biopsies hold significant potential for the minimally invasive diagnosis of tumors and other diseases. While the clinical application of cell-free DNA (cfDNA) methodologies is emerging, the implementation of tumor-derived extracellular vesicles (EVs) as validated biomarkers is hindered by substantial preanalytical variations. In this work, we standardized the preanalytical procedures of blood collection for subsequent serial isolation of plasma cfDNA and EVs from a single blood collection tube.

Methods

We compared the impact of blood preservation tubes and storage to enable proteomic profiling of resulting EVs in addition to cfDNA extraction and sequencing. Following a stringent method of large EV (lEV) and small EV (sEV) isolation, consisting of differential ultracentrifugation and size exclusion chromatography, we evaluated the protein concentration, particle number, quality and integrity of the isolated EVs. Subsequent proteomic analyses of EV isolates revealed the complexity of the respective tube-biased proteomes, allowing the interpretation of EV origins as well as contamination sources.

Results

While ACD-A and Citrate tubes yield satisfactory results in the preservation of EV proteomes, only Streck RNA, Norgen, and PAX tubes can maintain high cfDNA purity for up to 7 days. When aiming for multiomics analyses, Streck RNA tubes showed the most stable performance across the tested parameters for both bioanalytes. Furthermore, we detected greater variability in protein composition in sEVs than in lEVs after 7 days of storage; thus, sEVs might be more susceptible to storage effects.

Conclusion

Our clinically applicable workflow provides the basis for informed choice of liquid biopsy tubes along with a ready-to-use protocol to retrieve both genomic and EV proteomic biomarker information for multiomics biomarker-based liquid biopsy studies.

Schlagwörter

Stichwörter der Autor:innen

EV preservationcfDNAextracellular vesicleshuman plasmaisolation protocolliquid biopsypreanalyticstranslation

Autor:innen und Institutionen

  • Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Heidelberg 69120, Germany.
  • Hopp Children's Cancer Center Heidelberg (KiTZ) and NCT Heidelberg, Heidelberg 69120, Germany.
  • Medical Faculty, Heidelberg University, Mannheim 68167, Germany.
  • Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg 69120, Germany.
  • Junior Clinical Cooperation Unit Translational Lymphoma Research, German Cancer Research Center (DKFZ) Heidelberg, Mannheim 68169, Germany.
  • Department of Hematology and Oncology, Medical Faculty Mannheim, Heidelberg University, Mannheim 68167, Germany.

Zitieren

APA

Simon, N. K., Volz, S., Rios de Los Rios Reséndiz, J., Wedig, T., Montigel, S. H., Schwarz, N., Richter, K., Helm, D., Neßling, M., Zielske, L., Berker, J., Russeck, S., Mauermann, M., Hofmann, W. K., Pfister, S. M., Pajtler, K. W., Maaß, K. K., & Clemm von Hohenberg, K. (2025). Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNA. Extracellular Vesicles and Circulating Nucleic Acids, 626-50. https://doi.org/10.20517/evcna.2025.44

Vancouver

Simon NK, Volz S, Rios de Los Rios Reséndiz J, Wedig T, Montigel SH, Schwarz N, et al. Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNA. Extracellular Vesicles and Circulating Nucleic Acids. 2025:626-50. doi:10.20517/evcna.2025.44

BibTeX
@article{Simon2025,
  author = {Simon, Nike K and Volz, Stefanie and Rios de Los Rios Reséndiz, Jussara and Wedig, Tatjana and Montigel, Sophia H and Schwarz, Nathalie and Richter, Karsten and Helm, Dominic and Neßling, Michelle and Zielske, Lin and Berker, Julia and Russeck, Sophia and Mauermann, Monika and Hofmann, Wolf-Karsten and Pfister, Stefan M and Pajtler, Kristian W and Maaß, Kendra K and Clemm von Hohenberg, Katharina},
  title = {Preanalytical framework for routine clinical use of liquid biopsies: combining EVs and cfDNA},
  journal = {Extracellular Vesicles and Circulating Nucleic Acids},
  year = {2025},
  pages = {626--50},
  doi = {10.20517/evcna.2025.44}
}
Kostenlos starten →